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Background/aim: The purpose of this study was to evaluate the etiology, clinical characteristics, and outcome of nontraumatic coma
(NTC) among children admitted to a pediatric intensive care unit (PICU).
Materials and methods: A total of 159 children with NTC were included in the study. The modified Glasgow coma scale (GCS) was
used to assess consciousness. Patients were classified with regard to etiology. For each patient, demographic and clinical characteristics,
survival and degree of disability at PICU discharge were recorded.
Results: Median age was 55 months (IQR: 17.0 - 109.0). The most common cause of NTC was neuroinfection (31.4%) followed by toxicmetabolic conditions (25.8%) and epileptic disorder (15.1%). There was no significant relationship between the level of encephalopathy
at admission and NTC etiology. A total of 13 patients died (8.2%). Among the survivors, 61.6% were discharged without any neurologic
deficit, 2.8% had severe neurologic disability, and 3.4% were in a vegetative state. Complete neurological recovery was significantly
more common in patients with toxic metabolic disease, whereas neurological deficits were more frequent in patients with tuberculous
meningo-encephalitis (P = 0.01 and P = 0.04, respectively). Higher pediatric risk of mortality III (PRISM III) score at PICU admission
(Odds ratio: 1.51, 95% CI: 1.19 - 1.92; P < 0.001) was the only variable that was independently associated with mortality. The length of
stay (LOS) at hospital (Odds ratio: 0.73, 95% CI: 0.58-0.91; P = 0.006) was associated with improved odds of survival.
Conclusions: Although results obtained from this single-center study cannot be generalized to the pediatric population, the contribution
to the literature in terms of the relationships between NTC etiology, and outcome can be crucial for clinical decision-making. We report
neuroinfection as the most common cause of NTC, and the only factor that was closely associated with mortality was PRISM III score.
Length of hospital stay was inversely correlated to patient mortality.
Key words: Coma, nontraumatic, children, pediatric critical care, etiology, outcome

1. Introduction
Coma is a state of altered level of consciousness in which
there is a loss of both wakefulness and awareness of the
self and the environment. It is a very serious condition
that necessitates immediate medical decision making
upon arrival at the pediatric emergency department or
pediatric intensive care unit (PICU) [1]. The most common
scoring system used for assessment of consciousness is the
Glasgow coma scale (GCS), and a modified version of the
GCS is used in pediatric patients [2,3]. Pediatric coma
is generally defined as having a GCS of < 12 for at least
6 h [4]. Coma, without a history of a traumatic event, is
an accompanying feature of many different conditions,
including infectious, metabolic-toxic, and epileptic
etiologies. These conditions, or the coma resulting from

them, can be fatal if they are not swiftly identified and
sufficiently treated [5,6].
Usually, as a first diagnostic step, discrimination is
made between traumatic and nontraumatic coma (NTC).
However, in the pediatric population, the determination
of the cause of NTC (and thus, its etiology) is a challenge
for the physician; however, it is vital to making appropriate
treatment decisions. Etiology of coma and clinical status
at the time of admission are likely outcome predictors.
Although structural and nonstructural causes of coma may
overlap each other, discrimination should be made between
destructive structural brain lesion (cerebral hemisphere or
brain stem) and global acute physiological derangement of
brain function by performing case-specific investigations
in order to be able to manage patients appropriately [7].
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Most epidemiological studies about coma in children
have focused on traumatic coma [8,9]. The majority of
NTC studies in children have investigated the prognostic
analysis of specific etiologies (e.g. super-refractory
convulsive status epilepticus, posterior reversible
encephalopathy, virus associated encephalitis etc.)
[10,11,12]. There are only a few studies in which NTC has
been evaluated in terms of severity, etiology, and prognosis
[13,14]. In this study, our aim was to determine the etiology
and clinical characteristics of patients and the factors that
were associated with mortality and degree of disability
in pediatric patients with NTC who were admitted to a
tertiary-hospital PICU.
2. Materials and methods
This is a single-center, retrospective, and descriptive
study approved by İstanbul Medeniyet University Clinical
Research Ethics Committee (clinical study registration:
2019/0265). The study was conducted on patients aged 1
month to 17 years who were admitted to our tertiary PICU
between March 2015 and November 2019. The modified
GCS scoring system was used [3]. The GCS of patients and
its relationship with prognosis and etiology were assessed
by dividing the study population into three groups
depending on the level of consciousness at admission: the
first group was comprised of those with a GCS score of 1012 (mild encephalopathy), the second group had moderate
encephalopathy (GCS: 7-9), and the third group had severe
encephalopathy (GCS: 3-6) [14,15,16].
All patients who had a GCS of 12 or lower for at least 6
h at admission were included, given that they had normal
neurological development and did not have any history
of trauma. Exclusion criteria were as follows: (I) having
a history of trauma, (II) having a disease of the central
nervous system (CNS) or a systemic disease affecting the
CNS, (III) having a modified GCS higher than 12, (IV)
having a modified GCS score lower than 12 for less than
6 h.
The etiology of coma was determined on the basis of
history, clinical examination, neurological imaging, and
relevant laboratory investigations. Specific investigations,
such as cerebrospinal fluid analysis, liver function tests,
arterial blood gas analysis, electroencephalogram, and
neuroimaging studies (computerized tomography, CT
or magnetic resonance imaging, MRI) were performed
whenever necessary.
For each patient, the following data were collected:
demographic and clinical characteristics, admission
pediatric risk of mortality III (PRISM III) score and
predictive death rate (%PDR), clinical presentation
(seizure, vomiting, fever, headache, focal neurological
deficit, neck rigidity, personality changes, speech disorder,
abnormal pupillary reflex [absence of pupillary light

reflex and/or unequal pupillary light reflex], diplopia,
ataxia, opisthotonus), modified GCS score at admission,
mechanical ventilator requirement, length of stay (LOS) at
the PICU and hospital, survival, and degree of disability
at PICU discharge. The etiology of NTC was classified
as follows: (I) neuroinfection, (ii) toxic-metabolic, (iii)
epileptic, (iv) autoimmune disease, (v) stroke / vascular
pathology, (vi) cns tumour, (vii) hypoxic ischemic
encephalopathy, (viii) hypertensive encephalopathy, and
(ix) unknown etiology.
We evaluated degree of disability at PICU discharge
using the pediatric cerebral performance category (PCPC)
scales [17]. Scores on the PCPC run from 1 to 5, with the
following definitions: no symptoms (1: normal); alert
and able to interact at age-appropriate level but schoolage children may not have appropriate levels for age even
though they attend regular school classroom, possibility
of mild neurologic deficit (2: mild disability); sufficient
cerebral function for age-appropriate independent
activities of daily life, school-age child attending special
education classroom and/or having learning deficit (3:
moderate disability); dependent on others for daily activity
because of impaired brain function (4: severe disability);
unaware, even if awake in appearance, does not interact
with environment, cerebral unresponsiveness and no
evidence of cortex function, possibility of some reflexive
response, spontaneous eye-opening, and sleep-wake cycles
(5: vegetative state).
2.1. Statistical analysis
The data obtained from the study were evaluated via the
IBM SPSS (Version 15.0, SPSSInc., Chicago, IL, USA)
statistical package program. Normality of distribution
was tested (Shapiro-Wilk and Kolmogorov-Smirnov) and
normal distribution assumptions for the respective tests
were not met in any analysis. The frequency, percentage
(%), median, interquartile range (IQR) were used for
the depiction of descriptive data. Categorical data were
compared using Chi-square tests. The Mann-Whitney U
test was used to compare continuous variables. Univariate
logistic regression analysis and multivariate logistic
regression analysis were used to assess which factors were
effective on mortality (dependent variable). Variables
which were found to be associated with mortality in the
univariate analysis were determined as independent
variables. Statistical significance level was accepted as P <
0.05.
3. Results
3.1. Clinical characteristics and etiology
During the study period, a total of 1541 patients were
admitted to our PICU. Among these, 27.4% (n = 422) were
diagnosed with coma. The number of patients excluded
according to each exclusion criterion are as follows: 151
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patients due to traumatic coma, 46 patients due to having
> 12 modified GCS, 34 patients because they had primary
CNS disease or a systemic disease with known CNS
involvement, and 32 patients due to having GCS < 12 for
a duration shorter than 6 h. Finally, 159 encephalopathic
children with a diagnosis of NTC were included in the
study. The incidence of NTC meeting these criteria
was 10.3% of PICU admissions. Among these, 81 cases
(50.9%) were male and median age was 55 months (IQR:
17.0 - 109.0). The subjects included 33 children (20.8%)
aged from 1 month to 1 year, 54 children (34.0%) aged
from 1 year to 5 years and the greatest proportion of cases
with 72 children (45.2%) were aged > 5 years. The median
PRISM III score and %PDR at admission were 20.0 (IQR:
16.0 - 26.0) and 24.5 (IQR: 34.5 - 64.6) respectively. The
most common clinical presentation was seizure (52.2%),
followed by vomiting (41.5%) and fever (40.9%). Children
with NTC had a median GCS score of 9 (IQR: 7 - 11) at
admission, almost half of them had mild encephalopathy
(49.0%) followed by moderate encephalopathy (36.5%)
and severe encephalopathy (14.5%). Most patients needed
mechanical ventilator support (67.9%). The median LOS at
PICU was 6 days (IQR: 3 - 14), median LOS at hospital was
16 days (IQR: 6 - 27). Patients’ demographic and clinical
characteristics are detailed in Table 1.
The most common cause of NTC was neuroinfection
(n = 50, 31.4%). Among these patients, the most common
infectious etiology was viral encephalitis (n = 24, 15.0%)
followed by acute bacterial meningitis (n = 13, 8.1%). The
second and third most common etiologies were toxicmetabolic causes (n = 41, 25.8%) and epileptic causes
(n = 24, 15.1%), respectively. Other causes included
autoimmune diseases (9.4%), stroke/vascular pathologies
(6.3%) and CNS tumors (3.8%). The remaining 8 patients
(5%) had ‘unknown etiology’. Detailed etiological profile
has been summarized in Table 2.
There was no difference between boys and girls in
terms of etiological distribution. Neuroinfection was
significantly more common in the 1 month–1 year age
group (33.3%) (P = 0.04). Clinical presentations were
analyzed in relation to NTC etiologies, and it was found
that seizure was most common in the epileptic etiology
group. Further characterization of patients in this regard
showed that fever, vomiting, and neck rigidity were most
frequent in the infectious group; focal neurological signs
were most common in the stroke/vascular pathologies
group, while diplopia and ataxia were more common in
the CNS tumors group (P < 0.05 for all). There was no
significant relation between level of encephalopathy and
the different etiologies of NTC (P = 0.09).
3.2. Outcome
Overall, 146 patients (91.8%) survived and 13 patients died
(8.2%). Detailed etiologic distribution of dead children is
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Table 1. Demographic, clinical parameters, and outcome of
children with nontraumatic coma.
Patients characteristics
Sex, n (%)
Male
Female
Age (month), median (IQR)
Age group, n (%)
1 month-1 year
1-5 years
> 5 years
PRISM score on admission, median (IQR)
PDR (%) on admission, median (IQR)
Clinical presentation, n (%)
Seizure
Vomiting
Fever
Headache
Focal neurological deficit
Neck rigidity
Personality changes
Speech disorder
Abnormal pupillary reflex
Diplopia
Ataxia
Opisthotonus
Glasgow coma scale (GCS) on admission,
median (IQR)
Encephalopathy level on admission, n (%)
Mild (GCS 10-12)
Moderate (GCS 7-9)
Severe (GCS 3-6)
Need of ventilator support, n (%)
Required
Not required
LOS at PICU (days), median (IQR)
LOS at hospital (days), median (IQR)
Survival, n (%)
Alive
Dead
Degree of disability at PICU discharge, n (%)
Normal (w/o any disability)
Mild
Moderate
Severe
Vegetative

Value
81 (50.9)
78 (49.1)
55.0 (17.0-109.0)
33 (20.8)
54 (34.0)
72 (45.2)
20.0 (16.0-26.0)
24.5 (34.5-64.6)
83 (52.2)
66 (41.5)
65 (40.9)
30 (18.9)
17 (10.7)
11 (6.9)
11 (6.9)
8 (5.0)
8 (5.0)
7 (4.4)
7 (4.4)
5 (3.1)
9 (7–11)
78 (49.0)
58 (36.5)
23 (14.5)
108 (67.9)
51 (32.1)
6 (3-14)
15 (6-27)
146 (91.8)
13 (8.2)
90 (61.6)
14 (9.6)
33 (22.6)
4 (2.8)
5 (3.4)

PRISM: Pediatric risk of mortality; PDR: Predicted death rate;
LOS: Length of stay; PICU: Pediatric intensive care unit; IQR:
Interquartile range.
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Table 2. Etiological classification of patients with nontraumatic
coma.
Etiology

Frequency n (%)

Neuroinfection

50 (31.4)

Viral encephalitis

24 (15.0)

Acute bacterial meningitis

13 (8.1)

Virus-associated encephalitis

7 (4.4)

Tuberculosis meningo-encephalitis

2 (1.3)

Other

4 (2.6)

Toxic-metabolic

41 (25.8)

Neurometabolic diseases

14 (8.8)

Pharmaceutical poisoning

9 (5.7)

Diabetic ketoacidosis

8 (5.0)

Hepatic encephalopathy

6 (3.8)

Carbon monoxide poisoning

4 (2.5)

Epileptic

24 (15.1)

Febrile status epilepticus

13 (8.2)

Afebrile status epilepticus

11 (6.9)

Autoimmune disease

15 (9.4)

Autoimmune encephalitis

5 (3.1)

Acute disseminated encephalomyletitis

3 (1.9)

Autoimmune lymphoproliferative disease 2 (1.3)
Thrombotic thrombocytopenic purpura

1 (0.6)

Hashimato thyroiditis

1 (0.6)

Takayasu’s arteritis

1 (0.6)

Kawasaki disease

1 (0.6)

Haemolytic uremic syndrome

1 (0.6)

Stroke/Vascular pathology

10 (6.3)

Arteriovenous malformation

5 (3.3)

Sinus vein thrombosis

1 (0.6)

Moya moya disease

1 (0.6)

Ischemic infarct

1 (0.6)

Aneurysm rupture

1 (0.6)

Hemorrhagic disease of the newborn

1 (0.6)

Central nervous system tumor

6 (3.8)

Ependymoma

3 (1.9)

Astrocytoma

2 (1.3)

Arachnoid cyst

1 (0.6)

Hypoxic ischemic encephalopathy

3 (1.9)

Hypertensive encephalopathy

2 (1.3)

Unknown etiology

8 (5.0)

Total

159 (100.0)

shown in Table 3. Among the 146 survivors, 61.6% were
discharged from PICU without any neurological deficit,
9.6% had mild disability, 22.6% had moderate disability,
2.8% had severe disability, and 3.4% were in a vegetative
state (Table 1).
The relationships between NTC etiology and patient
outcome are presented in Table 3 and Table 4. Mortality
risk was found to be 5.96-fold (95% CI: 1.33-26.62) higher
in those who had stroke/vascular pathology as compared
to those who did not (P = 0.02). Other etiological factors
did not have a significant effect on mortality. Comparisons
revealed that complete neurological recovery was
significantly more common in patients with toxic metabolic
disease, whereas neurological deficits were more frequent
in patients with tuberculous meningo-encephalitis (P =
0.01 and P = 0.04, respectively).
In the univariate logistic regression analysis performed
to determine factors affecting mortality, it was found that
the risk of death was associated with high PRISM III score
at admission (Odds ratio: 1.33, 95% CI: 1.17-1.52; P <
0.001), severe encephalopathy at admission (Odds ratio:
20.27, 95% CI: 3.91-105.05; P < 0.001), and presence of
stroke/vascular pathology (Odds ratio: 5.96, 95% CI: 1.3326.62; P = 0.020) (Table 4). From all clinical presentations,
only the presence of abnormal light reflex (unequal or
nonreactive) was found to increase mortality risk (Odds
ratio: 8.46, 95% CI: 1.76-40.60; P = 0.008). The LOS at
hospital was associated with improved odds of survival
(Odds ratio: 0.82, 95% CI: 0.71-0.94; P = 0.004). Sex, age,
%PDR, need for ventilator support, LOS at PICU, other
etiological groups, and clinical presentations of NTC were
not found to be significant for the prediction of mortality.
Based on multivariate logistic regression analysis,
only the presence of higher PRISM III score at PICU
admission (Odds ratio: 1.51, 95% CI: 1.19-1.92; P < 0.001)
was independently associated with mortality. The LOS at
hospital was associated with improved odds of survival
(Odds ratio: 0.73, 95% CI: 0.58-0.91; P = 0.006). Severe
encephalopathy on admission, presence of stroke/vascular
pathology, and presence of abnormal light reflex were not
found to be significant in multivariate analysis (P = 0.68, P
= 0.91, P = 0.16, respectively).
4. Discussion
NTC is a significant health problem with considerable
morbidity and mortality in children. Timely diagnosis and
identification of pathological mechanisms and treatment
may be helpful in reducing morbidity and mortality. This
study reveals several important results about pediatric
NTC by reporting characteristics and relationships in its
presentation, cause, mortality, and shortterm neurological
outcome.
According to our study, the majority of patients were
in the > 5 years age group. In comparison, a study from
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Table 3. Detailed analysis evaluating the effect of etiological groups on mortality and morbidity of children with nontraumatic coma.
Outcome

Disability level

Etiology, n (%)

Total

Alive

Dead

P value

Normal

Mild

Medium Severe

Vegetative P value

Neuroinfection

50 (100.0)

46 (92.0)

4 (8.0)

0.96

25 (54.3)

7 (15.2)

11 (23.9) 1 (2.2)

2 (4.3)

0.54**

Viral encephalitis

24 (100.0)

23 (95.8)

1 (4.2)

0.39

14 (60.8)

3 (13.1)

5 (21.7)

1 (4.4)

0 (0.0)

0.54**

Enterovirus

9 (100.0)

9 (100.0)

0 (0.0)

8 (88.9)

0 (0.0)

1 (11.1)

0 (0.0)

0 (0.0)

Herpes simplex virus

6 (100.0)

6 (100.0)

0 (0.0)

2 (33.3)

3(50.0)

0 (0.0)

1 (16.7) 0 (0.0)

Cytomegalovirus

3 (100.0)

3 (100.0)

0 (0.0)

2 (66.7)

0 (0.0)

1 (33.3)

0 (0.0)

0 (0.0)

Adenovirus

2 (100.0)

2 (100.0)

0 (0.0)

1 (50.0)

0 (0.0)

1 (50.0)

0 (0.0)

0 (0.0)

Ebstein-Barr virus

1 (100.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (100.0) 0 (0.0)

0 (0.0)

Varicella zoster virus

1 (100.0)

1 (100.0)

0 (0.0)

1 (1000)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Human herpes virus 7

1 (100.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (100.0) 0 (0.0)

0 (0.0)

Rabies virus

1 (100.0)

0 (0.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Acute bacterial meningitis*

13 (100.0)

11 (84.6)

2 (15.4)

6 (54.5)

3 (27.3)

1 (9.1)

0 (0.0)

1 (9.1)

Neisseria meningitidis

6 (100.0)

4 (66.7)

2 (33.3)

2 (50.0)

2 (50.0)

0 (0.0)

0 (0.0)

0 (0.0)

Streptococcus pneumoniae

3 (100.0)

3 (100.0)

0 (0.0)

2 (66.7)

0 (0.0)

1 (33.3)

0 (0.0)

0 (0.0)

Haemophilus influenzae

2 (100.0)

2 (100.0)

0 (0.0)

2 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Escherichia coli

1 (100.0)

1 (100.0)

0 (0.0)

0 (0.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

Staphylococcus aureus

1 (100.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (100.0)

Virus-associated encephalitis

7 (100.0)

6 (85.7)

1 (14.3)

3 (50.0)

0 (0.0)

3 (50.0)

0 (0.0)

0 (0.0)

Influenza virus

5 (100.0)

4 (80.0)

1 (20.0)

2 (50.0)

0 (0.0)

2 (50.0)

0 (0.0)

0 (0.0)

Rotavirus

1 (100.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (100.0) 0 (0.0)

0 (0.0)

Parainfluenza virus

1 (100.0)

1 (100.0)

0 (0.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Tuberculosis meningo-encephalitis

2 (100.0)

2 (100.0)

0 (0.0)

1.00

0 (0.0)

0 (0.0)

1 (50.0)

0 (0.0)

1 (50.0)

0.01**

Other

4 (100.0)

4 (100.0)

0 (0.0)

1.00

2 (50.0)

1 (25.0)

1 (25.0)

0 (0.0)

0 (0.0)

0.16**

Hydatid Cyst

1 (100.0)

1 (100.0)

0 (0.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Actinomyces viscosus

1 (100.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (100.0) 0 (0.0)

0 (0.0)

Clostridium tetani

2 (100.0)

2 (100.0)

0 (0.0)

1 (50.0

1 (50.0)

0 (0.0)

0 (0.0)

0 (0.0)

41 (100.0)

39 (95.1)

2 (4.9)

0.38

26 (66.7)

3 (7.7)

7 (17.9)

2 (5.1)

1 (2.6)

Neuromethabolic disease

14 (100.0)

13 (92.9)

1 (7.1)

0.53

2 (15.4)

2 (15.4)

6 (46.2)

2 (15.4) 1 (7.7)

Urea cycle defect

2 (100.0)

2 (100.0)

0 (0.0)

1 (50.0)

0 (0.0)

1 (50.0)

0 (0.0)

0 (0.0)

Fatty acid oxidation defect

1 (100.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (100.0) 0 (0.0)

0 (0.0)

Fructose 1-6 diphosphatase

1 (100.0)

1 (100.0)

0 (0.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Neurotransmitter defect

1 (100.0)

0 (0.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Lipid storage disease

2 (100.0)

2 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (50.0)

1 (50.0) 0 (0.0)

Mitochondrial cytopathy

2 (100.0)

2 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (50.0) 1 (50.0)

Unspecified

5 (100.0)

5 (100.0)

0 (0.0)

0 (0.0)

2 (40.0)

3 (60.0)

0 (0.0)

0 (0.0)

Pharmaceutical poisoning

9 (100.0)

9 (100.0)

0 (0.0)

1.00

9 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

NA

Diabetic ketoacidosis

8 (100.0)

8 (100.0)

0 (0.0)

1.00

7(87.5)

0 (0.0)

1 (12.5)

0 (0.0)

0 (0.0)

NA

Hepatic encephalopathy*

6 (100.0)

5 (83.3)

1 (16.7)

5 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

NA

Carbon monoxide poisoning

4 (100.0)

4 (100.0)

0 (0.0)

1.00

3 (75.0)

1 (25.0)

0 (0.0)

0 (0.0)

0 (0.0)

NA

Epileptic

24 (100.0)

24 (100.0) 0 (0.0)

1.00

22 (91.7)

1 (4.2)

0 (0.0)

1 (4.2)

0 (0.0)

0.27**

Febrile status epilepticus

13 (100.0)

13 (100.0) 0 (0.0)

1.00

13 (100.0) 0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0.06**

Afebrile status epilepticus

11 (100.0)

11 (100.0) 0 (0.0)

1.00

9 (81.8)

0 (0.0)

1 (9.1)

0 (0.0)

0.22**

Toxic- metabolic

a
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0.33

0.55

1 (9.1)

0.09**

0.37**

0.04**
NA
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Table 3. (Continued).
Autoimmune diseases

15 (100.0)

14 (93.3)

1 (6.7)

Autoimmune encephalitis

6 (42.9)

1 (7.1)

7 (50.0)

0 (0.0)

0 (0.0)

5 (100.0)

4 (80.0)

ADEM

3 (100.0)

3 (100.0)

1 (20.0)

1 (25.0)

1 (25.0)

2 (50.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (33.3)

0 (0.0)

2 (66.7)

0 (0.0)

0 (0.0)

ALPD

2 (100.0)

TTP

1 (100.0)

2 (100.0)

0 (0.0)

1 (50.0)

0 (0.0)

1 (50.0)

0 (0.0)

0 (0.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (100.0) 0 (0.0)

0 (0.0)

Hashimato thyroiditis
Takayasu’s arteritis

1 (100.0)

1 (100.0)

0 (0.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (100.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (100.0) 0 (0.0)

0 (0.0)

Kawasaki disease

1 (100.0)

1 (100.0)

0 (0.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Hemolytic uremic syndrome

1 (100.0)

1 (100.0)

0 (0.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

10 (100.0)

7 (70.0)

3 (30.0)

1 (14.3)

2 (28.6)

2 (28.6)

0 (0.0)

2 (28.6)

Arteriovenous malformation

5 (100.0)

2 (40.0)

3 (60.0)

0 (0.0)

1 (50.0)

0 (0.0)

1 (50.0) 0 (0.0)

Sinus vein thrombosis

1 (100.0)

1 (100.0)

0 (0.0)

0 (0.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

Moya moya disease

1 (100.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (100.0) 0 (0.0)

0 (0.0)

Ischemic infarct

1 (100.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (100.0) 0 (0.0)

0 (0.0)

1 (100.0)

1 (100.0)

0 (0.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Hemorrhagic disease of the newborn 1 (100.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (100.0)

b
c

d

Stroke/Vascular pathology

Aneurysm rupture

*

Central nervous system tumor

0.82

0.02

1.00

0.85**

0.29**

6 (100.0)

6 (100.0)

0 (0.0)

1 (16.7)

0 (0.0)

5 (83.3)

0 (0.0)

0 (0.0)

Ependymoma

3 (100.0)

3 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

3 (100.0) 0 (0.0)

0 (0.0)

0.05**

Astrocytoma

2 (100.0)

2 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

2 (100.0) 0 (0.0)

0 (0.0)

Arachnoid cyst

1 (100.0)

1 (100.0)

0 (0.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Hypoxic ischemic encephalopathy

3 (100.0)

0 (0.0)

3 (100.0) 1.00

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

NA

Hypertensive encephalopathy

2 (100.0)

2 (100.0)

0 (0.0)

1.00

2 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0.87**

Unknown etiology

8 (100.0)

8 (100.0)

0 (0.0)

1.00

7 (87.5)

0 (0.0)

1 (12.5)

0 (0.0)

0 (0.0)

0.62**

Total

159 (100.0) 146 (91.8) 13 (8.2)

90 (61.6)

14 (9.6)

33 (22.6) 4 (2.8)

5 (3.4)

* Group referenced in logistic regression.
** P value obtained as a result of in-group Chi-square test.
a
Fructose 1-6 diphosphatase deficiency.
b
Acute disseminated encephalomyelitis.
c
: Autoimmune lymphoproliferative disease.
d
: Thrombotic thrombocytopenic purpura.
NA: Nonapplicable (sample size of one subgroup too small for comparition).

Nigeria found that the majority of children were between
1-5 years of age (62.5%) [18]. Another study from Saudi
Arabia reported higher incidence among young infants
[19]. We found that there was no influence of sex on
etiological distribution. However, regarding age groups in
relation to etiology, neuroinfection was most common in
the 1 month to 1 year age group. A study from Iran found
infectious encephalopathy most commonly in children < 2
years, whereas toxic coma was significantly more frequent
in the 2-6 year age group [20].
The majority of patients admitted to the PICU with NTC
in the current study had mild encephalopathy. Previous
studies in children have demonstrated varying frequencies
of encephalopathy findings at admission. For instance, a
study from Nigeria reported 79.5% of children were deeply

comatose at admission [18]. We also evaluated clinical
presentations in relation to NTC etiology and found that
seizure was (expectedly) the most common presentation
in the epileptic group, while the other relationships were
as follows: fever, vomiting, and neck rigidity in infectious
etiologies; focal neurological signs in stroke/vascular
etiologies; diplopia and ataxia in CNS tumors. However,
overall, there was no significant relationship between level
of encephalopathy and the different etiologies of NTC. In
a study from Japan, seizure incidence was lower in herpes
simplex virus (HSV) encephalitis as compared to the other
causes, whereas abnormal speech and behavior was reported
to be associated with influenza related encephalitis [21].
Among the children with NTC, neuroinfectious
etiology was the most common cause of encephalopathy
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Table 4. Univariate and multivariate logistic regression analysis for prediction of mortality.

Variables

Total

Alive

Dead

Male, n (%)

81 (100.0)

74 (91.4)

7 (8.6)

Female, n (%)*

78 (100.0)

72 (92.3)

6 (7.7)

Age (month), median (IQR)

55.0 (17.0-109.0)

1 month- 1 year

Univariate analysis

Multivariate analysis

Odd’s ratio (95% CI)

P value

Odd’s ratio (95% CI)

P value

1.14 (0.36-3.54)

0.83

55.5 (17.8-107.3) 36.0 (7.5-179.0)

1.00 (0.99-1.01)

0.77

33 (100.0)

28 (84.8)

5 (15.2)

(0.64-8.92)

0.19

1-5 years

54 (100.0)

51 (94.4)

3 (5.6)

0.79 (0.18-3.45)

0.75

> 5 years*

72 (100.)

67 (93.1)

5 (6.9)

PRISM score, median (IQR)

20.0 (16.0-26.0)

19.0 (15.0-24.0)

36.0 (32.0-41.0)

1.33 (1.17-1.52)

< 0.001

PDR (%), median (IQR)

34.5 (18.7-64.6)

29.9 (15.7-54.6)

93.5 (86.3-97.6)

1.00 (0.99-1.01)

0.15

1.51 (1.19-1.92)

0.001

Mild (GCS 10-12), n (%)*

78 (100.0)

76 (97.4)

2 (2.6)

Medium (GCS 7-9), n (%)

58 (100.0)

55 (94.8)

3 (5.2)

2.07 (0.33-12.82)

0.43

0.31 (0.02-5.23)

0.42

Severe (GCS 3-6), n(%)

23 (100.0)

15 (65.2)

8 (34.8)

20.27 (3.91-105.05)

<0.001

1.87 (0.09-37.73)

0.68

Required, n (%)*

108 (100.0)

95 (88.0)

13 (12.0)

Not required, n (%)

51 (100.0)

51 (100.0)

LOS in PICU (day), median (IQR)

6 (3-14)

6.0 (3.0-14.3)

0 (0.0)

0.00 (0.00-..)

0.99

5.0 (3.0-7.0)

0.95 (0.87-1.04)

0.24

LOS in hospital (day), median (IQR)

15 (6-27)

16.0 (9.0-28.0)

5.0 (3.0-7.0)

0.82 (0.71-0.94)

0.004

0.73 (0.58-0.91)

0.006

Neuroinfections

50 (100.0)

46 (92.0)

4 (8.0)

0.96 (0.28-3.30)

0.96

Toxic-metabolic

41 (100.0)

39 (95.1)

2 (4.9)

0.50 (0.11-2.35)

0.38

Epileptic

24 (100.0)

24 (100.0)

0 (0.0)

0.00 (0.00-…)

1.00

Autoimmune

15 (100.0)

14 (93.3)

1 (6.7)

0.79 (0.09-6.50)

0.82

Stroke/Vascular pathology

9 (100.0)

7 (77.8)

2 (22.2)

5.96 (1.33-26.62)

0.02

1.94 (0.00-118315.40)

0.91

Central nervous system tumor

6 (100.0)

6 (100.0)

0 (0.0)

0.00 (0.00-…)

1.00

Hypoxic ischemic encephalopathy

2 (100.0)

2 (100.0)

0 (0.0)

23558593304 (0.00-…) 1.00

Hypertensive encephalopathy

3 (100.0)

0 (0.0)

3 (100.0)

0.00 (0.00-…)

1.00

Unknown etiology

8 (100.0)

8 (100.0)

0 (0.0)

0.00 (0.00-…)

1.00

Sex

Age group, n (%)

Need of ventilator support

Etiology of coma, n (%)

* Referenced group in logistic regression. PRISM: Pediatric risk of mortality; PDR: Predicted death rate; GCS: Glasgow coma score; LOS: Length of stay; PICU: Pediatric
intensive care unit; IQR: Interquartile range.
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Encephalopathy level on admission
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with viral encephalitis being the most frequent diagnosis.
A study from Turkey found that hypoxic ischemic
encephalopathy (HIE) and neuroinfection were the most
common causes of NTC [22]. Similarly, studies from other
countries like Pakistan, India, United Kingdom, Nigeria,
Malaysia, and Saudi Arabia also reported neuroinfection
as a leading cause of NTC [4,13,19,23-25]. In the current
study, among the etiological agents of viral encephalitis,
we found that enterovirus and HSV were present in more
than half of the children. Similar results were found
previously in a study from Pakistan [23]. However, the
type and pattern of neuroinfection differs with regard to
the characteristics of the country. For example, cerebral
malaria was predominant in Africa, while dengue fever
was common in South East Asia [24,26]. In Japan, virusassociated encephalitis was reported as the most common
cause of acute encephalitis with influenza and rotavirus
as the leading pathogens [27]. In our study, when we
evaluated patients with neuroinfection, virus-associated
encephalitis was found as the 3rd most common etiology
of NTC following viral encephalitis and acute bacterial
meningitis. Within the etiological agents of virusassociated encephalitis, we found influenza as the most
common causative agent, indicating a resemblance to the
study from Japan. In our study, the most common etiology
of acute bacterial meningitis was Neisseria meningitides,
similar to a multicenter surveillance study from Turkey
that reported the same organism as the most frequently
encountered cause of acute bacterial meningitis in children
[28]. It is interesting that various unusual pathological
agents were identified in the study, including Rabies virus,
Clostridium tetani, and Hydatid cyst. Also, a wide variety
of etiologies including rare diseases were present within the
current study population, indicating that our study group
was diverse and heterogeneous. This was most probably
caused by the fact that ours was a tertiary healthcare center
with a high number of referrals from other centers.
Among the noninfectious causes of NTC, toxicmetabolic etiologies were reported rather frequently
in previous studies [13,25]. Particularly in developed
countries, HIE and toxic-metabolic causes are determined
in a great majority of patients [29,30]. In our study,
the second most common etiology of NTC was toxicmetabolic causes. A study from Iran that included 123
children reported the most common cause of NTC as toxic
encephalopathy (followed by infectious encephalopathy)
[20]. In a series from Nigeria, epileptic encephalopathy
was reported as the second most common cause of NTC
[24]. In contrast, epileptic encephalopathy was the third
frequent etiology in our study. Unlike pediatric studies,
infectious causes are less frequent in adult studies. In a
large series including 865 adult patients, the most common
etiologies of coma were toxic (poisoning) causes and stroke

(intracranial hemorrhage or infarct) [31]. Stroke is rarely
encountered in the pediatric age group and the diagnosis
is usually delayed. It must be noted that, in the pediatric
population, such rare etiologies should be considered in
the differential diagnosis of coma and early neurological
imaging should be performed in case of suspicion [32]. In
our study, stroke/vascular pathologies were found in 6.3%
of patients, and the most common underlying condition
was arteriovenous malformation.
The current study reports a mortality rate of 8.2% in
pediatric patients with NTC, whereas mortality rates in
the literature range between 12.0% and 36.0% [4,13,23,25].
Also, it is important to note that previous studies report
higher mortality rate in NTC compared to traumatic coma
[19]. An important proportion of patients (61.6%) were
discharged without any disability in the current study.
This is in contrast with the report of Forsyth et al. who
highlighted the presence of high cognitive dysfunction
in children with NTC [33]. In a study from India, 11% of
children had full recovery, while a very high proportion of
patients (54%) had neurological impairment [34].
Logistic regression analysis for the accurate prediction
of mortality and short-term neurological disability revealed
no influence of age and sex on mortality and neurological
sequelae. In India, a higher mortality in children < 3 years
was found due to higher frequency of toxic and metabolic
causes, intracranial bleeding, and neuroinfection in this
age group [13]. In our study, mortality risk was found
to be 5.9 times higher in those who had stroke/vascular
pathology as compared to those who did not. However, in
multivariate analysis, this relationship was insignificant.
We also evaluated whether clinical findings at admission
were related to mortality. We concluded that, only the
presence of abnormal pupillary light reflex was associated
with mortality; however, this relationship was insignificant
when assessed as an independent risk factor. Previous
studies have reported that the absence of pupillary light
reflex is associated with unfavorable neurological outcome
and mortality [22]. In the present study, the absence of
pupillary light reflex and unequal pupillary light reflex
findings were evaluated together, which may have caused
variations in results. The relationships between mortality
and GCS score at admission have been exhaustively
investigated. In the literature, many studies report that low
GCS score is associated with mortality and unfavorable
neurological outcome [15,35]; whereas, studies reporting
no relationship also exist [19]. In our study, we could not
find a relationship between GCS score and mortality or
neurological outcome. Only high PRISM III score was
associated with mortality as an independent risk factor.
Also, the length of hospital stay was found to be positively
related with survival rate. We think that this is due to the
fact that survivors had longer stay due to the continuation
of their treatment and rehabilitation process.
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There are some limitations to be discussed. Firstly, the
retrospective nature of the study prevented the evaluation
of long-term outcomes. Even though short-term outcomes
were assessed at discharge, these examinations cannot
replace follow-up studies of cognitive and psychosocial
functions after discharge. Thus, our results may be
hampered by the possibility of cognitive worsening
after PICU discharge. Furthermore, the limitations
of neurological assessment in infants may also be an
important problem that could have been avoided if longterm evaluations could have been performed. Finally,
although appropriate statistical analyses were applied to
minimize error, this study cannot be generalized to the
whole pediatric population in Turkey. However, we believe
our study group is an extremely good representation of
NTC cases that can be seen in any center, particularly
due to the high number of patient referrals that are often
received from the whole country.
A better understanding about etiology and outcome
in pediatric patients with NTC will be helpful in the
management of such children. In the current study, the
most common etiology of NTC was neuroinfection
followed by toxic metabolic causes in our pediatric
population. However, cause of NTC may vary according
to the development level of countries, geographical
location and even due to differences between regions in
the same country. Therefore, for the differential diagnosis
of coma, clinicians should be aware that NTC causes may
differ depending on the region. Among the many clinical

and epidemiological characteristics evaluated in patients
with NTC, we found that only high PRISM III score
was associated with mortality. Length of hospital stay
was significantly longer in survivors. This may be due to
the possibility that diseases of CNS may require longer
treatment and rehabilitation. Prospective multicenter
studies with larger groups following patients for a longer
period of time will be useful for better evaluation and
analysis of factors affecting neurological outcome and
survival of patients.
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